WebJan 11, 2024 · Available Products. Activase intravenous lyophilized powder for injection, Genentech, 100 mg, kit, 1 count, NDC 50242-0065-27. Activase intravenous lyophilized powder for injection, Genentech, 50 mg, kit, 1 count, NDC 50242-0044-13. WebCathflo® Activase® (alteplase) is indicated for the restoration of function to central venous access devices as assessed by the ability to withdraw blood. Contraindications Cathflo Activase should not be administered to patients with known hypersensitivity to alteplase or any component of the formulation. Precautions General
GENENTECH SIGNS ON BOEHRINGER INGELHEIM SALES FORCE TO DETAIL ACTIVASE ...
WebData suggesting that tenecteplase is at least noninferior to alteplase, as well as its more convenient dosing, has led to its increased use. Ongoing studies are evaluating newer thrombolytics and adding antithrombotic therapy to IV thrombolysis. ESSENTIAL POINTS IV thrombolysis remains the most common acute stroke treatment. Advances in acting ... WebActivase® (alteplase) is indicated for the treatment of acute ischemic stroke (AIS). Exclude intracranial hemorrhage as the primary cause of stroke signs and symptoms prior to initiation of treatment. Initiate treatment as soon … hawaiian islands decals for cars
Genentech Pro CATHFLO® ACTIVASE® (alteplase)
WebSep 13, 2024 · The recommended dose is 0.9 mg/kg (not to exceed 90 mg total dose), with 10% of the total dose administered as an initial intravenous bolus over 1 minute and the remainder infused over 60 minutes. During and following Activase administration for the treatment of acute ischemic stroke, frequently monitor and control blood pressure. WebGenentech Pro ACTIVASE® (alteplase) Products ACTIVASE ® (alteplase) Activase Website Prescribing Information Safety Access Solutions Quick Enroll My Patient Solutions Login Frequently Asked Questions My Activase is spoiled, expired, or damaged, how do I get a replacement? How do I order educational materials for Activase? Web51412702. Volume. 58 Million IU. Features. Activase is a tissue plasminogen activator (tPA) indicated for the treatment of Acute Ischemic Stroke (AIS), Acute Myocardial Infarction (AMI) to reduce mortality and incidence of heart failure or Acute Massive Pulmonary Embolism (PE) for lysis. Activase is proven to reduce disability in patients ... bosch professional kreuzlinienlaser gcl 2-50